Wednesday morning brought a fresh wave of anxiety to Wall Street, with stock futures declining across the board as investors juggled inflation data, an impending Supreme Court decision, and the kickoff of earnings season.
Major index futures opened lower following Tuesday's subdued close. The Dow Jones futures fell 0.15%, while both S&P 500 and Nasdaq 100 futures declined 0.16%. The Russell 2000 managed a modest 0.14% gain, suggesting some continued appetite for smaller-cap names.
The Consumer Price Index offered a mixed bag for inflation watchers. December's headline CPI rose 2.7% year over year, matching both the previous month's reading and economists' expectations. The more closely watched core CPI, which strips out volatile food and energy prices, came in at 2.6% annually, just a hair below what Wall Street had anticipated. Not exactly a game-changer, but enough to keep rate-cut hopes alive for later in the year.
But the real drama might unfold later today. After last week passed without a decision, investors are now laser-focused on Wednesday's scheduled Supreme Court opinion release, which could include a ruling on challenges to President Donald Trump's tariff authority. The uncertainty around trade policy continues to hang over markets like a storm cloud that won't quite break.
Meanwhile, bond markets showed relatively calm waters. The 10-year Treasury yield stood at 4.17%, while the two-year note yielded 3.52%. According to the CME Group's FedWatch tool, markets are pricing in a 97.2% likelihood that the Federal Reserve will keep interest rates unchanged at its January meeting. Translation: don't expect any monetary policy fireworks this month.
The SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ Trust ETF (QQQ), which track the S&P 500 and Nasdaq 100 respectively, both traded lower in premarket action Wednesday. SPY dropped 0.15% to $692.73, while QQQ fell 0.20% to $625.00.
Stocks Making Moves
Wells Fargo Faces Earnings Test
Wells Fargo & Co (WFC) slipped 0.81% in premarket trading as the banking giant prepares to report quarterly results before the opening bell. Wall Street analysts are expecting earnings of $1.67 per share on revenue of $21.65 billion. The big question: how well did the bank navigate the fourth quarter's interest rate environment and loan demand dynamics?
From a technical perspective, Wells Fargo maintains a stronger price trend across short, medium, and long-term timeframes, paired with a moderate quality ranking. The stock has shown resilience despite broader banking sector headwinds.
BP's Energy Transition Hits a Speed Bump
BP PLC (BP) took a serious hit, dropping 1.84% after announcing that its energy transition businesses were facing a writedown of up to $5 billion. That's the kind of number that makes shareholders wince and raises questions about the pace and profitability of the company's shift toward renewable energy.
The British oil giant maintains a stronger price trend over medium and long-term periods but has struggled in the short term, though it does carry a solid value ranking. The writedown news certainly won't help that short-term picture.
WeRide Accelerates Into WeChat
WeRide Inc. ADR (WRD) climbed 1.59% after launching its Robotaxi Mini Program called "WeRide Go" on Tencent WeChat. The integration allows users in operating areas to book autonomous taxi rides directly through WeChat without downloading a separate app. That's a smart move in China, where WeChat is essentially the everything app.
The autonomous vehicle company shows a weaker price trend over medium and long-term horizons but has demonstrated strong momentum in the short term, suggesting growing investor enthusiasm for its expansion strategy.
TG Therapeutics Delivers Optimistic Outlook
TG Therapeutics Inc. (TGTX) surged 6.99% after releasing preliminary fourth-quarter revenue estimates and providing an optimistic outlook for 2026. When a biotech company gives better-than-expected guidance, investors tend to pay attention.
Despite the pop, TGTX maintains a weaker price trend across short, medium, and long-term timeframes, though it does carry a moderate value ranking. The positive guidance could signal a potential turning point for the stock's technical picture.
Gelteq Soars on Cannabinoid Platform Results
Gelteq Ltd. (GELS) absolutely exploded, jumping 56.04% after reporting positive preclinical results for its cannabinoid oral gel delivery platform. That's the kind of move that gets day traders excited and reminds everyone why biotech stocks carry such volatility.
The company maintains a stronger price trend over short and medium terms but shows weakness in the long term. Given the early-stage nature of the platform, investors will be watching closely to see if this momentum can sustain itself.
Tuesday's Market Recap
Looking back at Tuesday's session, Energy and Consumer Staples sectors managed to eke out gains, while Financials and Consumer Discretionary took the biggest hits. The Dow Jones fell 0.80% to close at 49,191.99, underperforming the broader market. The S&P 500 declined a more modest 0.19% to finish at 6,963.74, while the Nasdaq Composite dipped just 0.10% to 23,709.87. The Russell 2000 barely budged, falling 0.098% to 2,633.10.




